BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30288342)

  • 1. A point mutation in the
    Almeida FF; Tognarelli S; Marçais A; Kueh AJ; Friede ME; Liao Y; Willis SN; Luong K; Faure F; Mercier FE; Galluso J; Firth M; Narni-Mancinelli E; Rais B; Scadden DT; Spallotta F; Weil S; Giannattasio A; Kalensee F; Zöller T; Huntington ND; Schleicher U; Chiocchetti AG; Ugolini S; Herold MJ; Shi W; Koch J; Steinle A; Vivier E; Walzer T; Belz GT; Ullrich E
    Oncoimmunology; 2018; 7(10):e1475875. PubMed ID: 30288342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s.
    Sheppard S; Schuster IS; Andoniou CE; Cocita C; Adejumo T; Kung SKP; Sun JC; Degli-Esposti MA; Guerra N
    Cell Rep; 2018 Mar; 22(13):3385-3392. PubMed ID: 29590608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional ablation of NKp46+ cells using a novel Ncr1(greenCre) mouse strain: NK cells are essential for protection against pulmonary B16 metastases.
    Merzoug LB; Marie S; Satoh-Takayama N; Lesjean S; Albanesi M; Luche H; Fehling HJ; Di Santo JP; Vosshenrich CA
    Eur J Immunol; 2014 Nov; 44(11):3380-91. PubMed ID: 25142413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependence of innate lymphoid cell 1 development on NKp46.
    Wang Y; Dong W; Zhang Y; Caligiuri MA; Yu J
    PLoS Biol; 2018 Apr; 16(4):e2004867. PubMed ID: 29702643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.
    Narni-Mancinelli E; Gauthier L; Baratin M; Guia S; Fenis A; Deghmane AE; Rossi B; Fourquet P; Escalière B; Kerdiles YM; Ugolini S; Taha MK; Vivier E
    Sci Immunol; 2017 Apr; 2(10):. PubMed ID: 28480349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression.
    Glasner A; Isaacson B; Viukov S; Neuman T; Friedman N; Mandelboim M; Sexl V; Hanna JH; Mandelboim O
    Sci Rep; 2017 Oct; 7(1):13090. PubMed ID: 29026144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKp46 Calibrates Tumoricidal Potential of Type 1 Innate Lymphocytes by Regulating TRAIL Expression.
    Turchinovich G; Ganter S; Bärenwaldt A; Finke D
    J Immunol; 2018 Jun; 200(11):3762-3768. PubMed ID: 29661825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
    Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
    J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity.
    Glasner A; Roth Z; Varvak A; Miletic A; Isaacson B; Bar-On Y; Jonjic S; Khalaila I; Mandelboim O
    Cell Discov; 2015; 1():15036. PubMed ID: 27462433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.
    Glasner A; Ghadially H; Gur C; Stanietsky N; Tsukerman P; Enk J; Mandelboim O
    J Immunol; 2012 Mar; 188(6):2509-15. PubMed ID: 22308311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zbtb1 controls NKp46
    Lu Y; Zhang X; Bouladoux N; Kaul SN; Jin K; Sant'Angelo D; Belkaid Y; Kovalovsky D
    Oncotarget; 2017 Aug; 8(34):55877-55888. PubMed ID: 28915559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of NK-Activating Receptor-NKp46/NCR1 on NK Cells in Patients with Severe Aplastic Anemia.
    Fu R; Liu H; Zhang J; Liu C; Ding S; Li L; Wang H; Wang G; Song J; Shao Z
    Clin Lab; 2015; 61(9):1221-9. PubMed ID: 26554241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noé).
    Glasner A; Isaacson B; Mandelboim O
    Sci Rep; 2017 Jan; 7():40944. PubMed ID: 28134248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.
    Bar-On Y; Charpak-Amikam Y; Glasner A; Isaacson B; Duev-Cohen A; Tsukerman P; Varvak A; Mandelboim M; Mandelboim O
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells.
    Sen Santara S; Lee DJ; Crespo Â; Hu JJ; Walker C; Ma X; Zhang Y; Chowdhury S; Meza-Sosa KF; Lewandrowski M; Zhang H; Rowe M; McClelland A; Wu H; Junqueira C; Lieberman J
    Nature; 2023 Apr; 616(7956):348-356. PubMed ID: 37020026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.
    Halfteck GG; Elboim M; Gur C; Achdout H; Ghadially H; Mandelboim O
    J Immunol; 2009 Feb; 182(4):2221-30. PubMed ID: 19201876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eomes Expression Defines Group 1 Innate Lymphoid Cells During Metastasis in Human and Mouse.
    Verma R; Er JZ; Pu RW; Sheik Mohamed J; Soo RA; Muthiah HM; Tam JKC; Ding JL
    Front Immunol; 2020; 11():1190. PubMed ID: 32625207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and Functional Plasticity of Murine Intestinal NKp46+ Group 3 Innate Lymphoid Cells.
    Verrier T; Satoh-Takayama N; Serafini N; Marie S; Di Santo JP; Vosshenrich CA
    J Immunol; 2016 Jun; 196(11):4731-8. PubMed ID: 27183613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor HIF-1α mediates plasticity of NKp46+ innate lymphoid cells in the gut.
    Krzywinska E; Sobecki M; Nagarajan S; Zacharjasz J; Tambuwala MM; Pelletier A; Cummins E; Gotthardt D; Fandrey J; Kerdiles YM; Peyssonnaux C; Taylor CT; Sexl V; Stockmann C
    J Exp Med; 2022 Feb; 219(2):. PubMed ID: 35024767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of NKp46(+) Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues.
    Tomasello E; Yessaad N; Gregoire E; Hudspeth K; Luci C; Mavilio D; Hardwigsen J; Vivier E
    Front Immunol; 2012; 3():344. PubMed ID: 23181063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.